EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role and prospect of lysine‐specific demethylases in cancer chemoresistance

Ying-Qi Song, Guan-Jun Yang iD, Dik-Lung Ma, Wanhe Wang, Chung-Hang Leung iD

Medicinal Research Reviews · 2023

DOI: 10.1002/med.21955 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, 2023. Verfasst von Ying-Qi Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. Hauptthemen laut MEDLINE: Histones, Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 238 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histone methylation plays a key function in modulating gene expression, and preserving genome integrity and epigenetic inheritance. However, aberrations of histone methylation are commonly observed in human diseases, especially cancer. Lysine methylation mediated by histone methyltransferases can be reversed by lysine demethylases (KDMs), which remove methyl marks from histone lysine residues. Currently, drug resistance is a main impediment for cancer therapy. KDMs have been found to mediate drug tolerance of many cancers via altering the metabolic profile of cancer cells, upregulating the ratio of cancer stem cells and drug‐tolerant genes, and promoting the epithelial‐mesenchymal transition and metastatic ability. Moreover, different cancers show distinct oncogenic addictions for KDMs. The abnormal activation or overexpression of KDMs can alter gene expression signatures to enhance cell survival and drug resistance in cancer cells. In this review, we describe the structural features and functions of KDMs, the KDMs preferences of different cancers, and the mechanisms of drug resistance resulting from KDMs. We then survey KDM inhibitors that have been used for combating drug resistance in cancer, and discuss the opportunities and challenges of KDMs as therapeutic targets for cancer drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesNeoplasmsHumansLysineHistone DemethylasesDrug Resistance, Neoplasm

Stichwörter der Autor:innen

cancerdrug resistanceepigeneticsinhibitorlysine-specific demethylases

Substanzen

HistonesLysineHistone Demethylases

Autor:innen und Institutionen

  • State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.
  • State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Ningbo University, Ningbo, Zhejiang, China.
  • Laboratory of Biochemistry and Molecular Biology, School of Marine Sciences, Ningbo University, Ningbo, Zhejiang, China.
  • Department of Chemistry, Hong Kong Baptist University, Hong Kong, China.
  • Institute of Medical Research, Northwestern Polytechnical University, Xi'an, Shaanxi, China.
  • Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Macao, China.

ORCID-Profile: Guan-Jun Yang, Chung-Hang Leung

Zitieren

APA

Song, Y. Q., Yang, G. J., Ma, D. L., Wang, W., & Leung, C. H. (2023). The role and prospect of lysine‐specific demethylases in cancer chemoresistance. Medicinal Research Reviews. https://doi.org/10.1002/med.21955

Vancouver

Song YQ, Yang GJ, Ma DL, Wang W, Leung CH. The role and prospect of lysine‐specific demethylases in cancer chemoresistance. Medicinal Research Reviews. 2023. doi:10.1002/med.21955

BibTeX
@article{Song2023,
  author = {Song, Ying-Qi and Yang, Guan-Jun and Ma, Dik-Lung and Wang, Wanhe and Leung, Chung-Hang},
  title = {The role and prospect of lysine‐specific demethylases in cancer chemoresistance},
  journal = {Medicinal Research Reviews},
  year = {2023},
  doi = {10.1002/med.21955}
}
Kostenlos starten →